McIlrath & Eck’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,000
Closed -$42K 926
2022
Q3
$42K Buy
+2,000
New +$57.1K 0.01% 273
2022
Q2
Sell
-1,000
Closed -$41K 893
2022
Q1
$41K Buy
+1,000
New +$41.9K 0.01% 273

Other funds holding ELAT

McIlrath & Eck's ELAT Position: Q4 2022 in Review

McIlrath & Eck sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q4 2022, closing a stake of 2,000 shares — an estimated $42K sold.

McIlrath & Eck first reported a position in ELAT in Q1 2022 and held it in 2 quarters. The position peaked at $42K in Q3 2022. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.

  • McIlrath & Eck reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q4 2022 after selling out during the quarter.
  • McIlrath & Eck sold 2,000 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q4 2022, an estimated $42K.
  • McIlrath & Eck first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2022 and held it in 2 quarters.
  • McIlrath & Eck's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $42K in Q3 2022.
  • 27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.

Based on McIlrath & Eck's 13F filing for Q4 2022, filed 15 Feb 2023.